Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse

  • A. T
  • Y. M
  • Y. M
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

The increasing popularity of the Cre/loxP recombination system has led to the generation of numerous transgenic mouse lines in which Cre recombinase is expressed under the control of organ- or cell-specific promoters. Alterations in retinal pigment epithelium (RPE), a multifunctional cell monolayer that separates the retinal photoreceptors from the choroid, are prevalent in the pathogenesis of a number of ocular disorders, including age-related macular degeneration. To date, six transgenic mouse lines have been developed that target Cre to the RPE under the control of various gene promoters. However, multiple lines of evidence indicate that high levels of Cre expression can be toxic to mammalian cells. In this study, we report that in the Trp1-Cre mouse, a commonly used transgenic Cre strain for RPE gene function studies, Cre recombinase expression alone leads to RPE dysfunction and concomitant disorganization of RPE layer morphology, large areas of RPE atrophy, retinal photoreceptor dysfunction, and microglial cell activation in the affected areas. The phenotype described herein is similar to previously published reports of conditional gene knockouts that used the Trp1-Cre mouse, suggesting that Cre toxicity alone could account for some of the reported phenotypes and highlighting the importance of the inclusion of Cre-expressing mice as controls in conditional gene targeting studies. 2012 American Society for Investigative Pathology.

Cite

CITATION STYLE

APA

A., T., Y., M., Y., M., A., G., D., M., M., K., … D.G., V. (2012). Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse. American Journal of Pathology. D.G. Vavvas, Retina Service, Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles St., Boston, MA, 02114, United States. E-mail: vavvas@meei.harvard.edu: Elsevier Inc. (360 Park Avenue South, New York NY 10010, United States). Retrieved from http://0-ovidsp.ovid.com.wam.city.ac.uk/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=2012236871

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free